Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-12-191511
Filing Date
2012-04-27
Accepted
2012-04-27 17:01:44
Documents
5
Period of Report
2011-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 10-K d340370d10ka.htm 10-K/A 807173
2 JAZZ PHARMACEUTICALS PLC CASH BONUS PLAN d340370dex1033.htm EX-10.33 23629
3 AMENDED AND RESTATED EXECUTIVE CHANGE IN CONTROL AND SEVERANCE BENEFIT PLAN d340370dex1034.htm EX-10.34 112062
4 CERTIFICATION OF CEO PURSUANT TO RULES 13A-14(A) AND 15D-14(A) d340370dex313.htm EX-31.3 3641
5 CERTIFICATION OF CFO PURSUANT TO RULES 13A-14(A) AND 15D-14(A) d340370dex314.htm EX-31.4 3647
  Complete submission text file 0001193125-12-191511.txt   951217
Mailing Address 45 FITZWILLIAM SQUARE DUBLIN L2 2
Business Address 45 FITZWILLIAM SQUARE DUBLIN L2 2 353 1 634 4183
Azur Pharma Public Ltd Co (Filer) CIK: 0001529938 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 333-177528 | Film No.: 12790693
SIC: 2834 Pharmaceutical Preparations